SPECT imaging using [123I] β-CIT and [123I] IBF in extrapyramidal diseases

Brain and Nerve

Volumn 55, Issue 1, 2003, Pages 57-64

  Sasaki, Takahiro ^a   Amano, Takahiro ^a   Hashimoto, Jun ^a   Itoh, Yoshiaki ^a   Muramatsu, Kazuhiro ^a   Kubo, Atsushi ^a   Fukuuchi, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Dopamine receptor; Dopamine transporter; Extrapyramidal diseases; SPECT

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER I 123; 5 IODO 7 N [(1 ETHYL 2 PYRROLIDINYL)METHYL]CARBOXAMIDO 1,3 DIHYDROBENZOFURAN I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 5 IODO N ((1 ETHYL 2 PYRROLIDINYL)METHYL) 2,3 DIHYDROBENZOFURANCARBOXAMIDE; 5-IODO-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-2,3-DIHYDROBENZOFURANCARBOXAMIDE; BENZOFURAN DERIVATIVE; CARRIER PROTEIN; COCAINE; DIAGNOSTIC AGENT; DOPAMINE TRANSPORTER; DRUG DERIVATIVE; MEMBRANE PROTEIN; NERVE PROTEIN; PYRROLIDINE DERIVATIVE; RADIOACTIVE IODINE;

ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DOPAMINERGIC SYSTEM; EXTRAPYRAMIDAL SYNDROME; HUMAN; NEUROLOGIC DISEASE; NEURORADIOLOGY; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PROGRESSIVE SUPRANUCLEAR PALSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; AGED; MIDDLE AGED; SCINTISCANNING;

AGED; BASAL GANGLIA DISEASES; BENZOFURANS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; IODINE RADIOISOTOPES; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PYRROLIDINES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0037225911     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bernheimer H, Birkmayer W, Hornykiewcz O, Jellingerr K, Seitelberger F: Brain dopamine and syndromes of Parkinson and Huntington. J Neurol Sci 30: 415-445, 1975
2. 11Craclopride and positron emission tomography. Ann Neurol 31: 184-192, 1992
3. 123I] beta-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect 94: 137-146, 1993
4. Critchley M: Arteriosclerotic parkinsonism. Brain 52: 23-83, 1929
5. Fearnley JM, Lees AJ: Aging and Parkinson's disease: Substantia nigra regional selectivity. Brain 114: 2283-2301, 1991
6. Hashimoto J, Sasaki T, Ogawa K, Kubo A, Motomura N, Ichihara T, Amano T, Fukuuchi Y: Effects of scatter and attenuation correction on quantitative analysis of β-CIT brain SPET. Nucl Med Commun 20: 159-165, 1999
7. Hoehn MM, Yahr MD: Parkinsonism: Onset, progression and mortality. Neurology 6: 253-259, 1967
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184, 1992
9. Jellinger K: Pathology of Parkinson's syndrome. pp 47-112 (ed by Calne DB: In Drugs for the Treatment of Parkinson's Disease, Springer-Verlag, Berlin, 1989)
10. Lang AE, Riley DE, Bergeron C: Cortical-basal ganglionic degeneration. pp 877-894 (ed by Calne DB: In Neurodegenerative Diseases, WB Saunders, Philadelphia, 1994)
11. Mozley PD, Stubbs JB, Kung HF, Selikson MH, Stabin MG, Alavi A: Biodistribution and dosimetry of iodine123-IBF: A potent radioligand for imaging the D 2 dopamine receptor. J Nucl Med 34: 1910-1917, 1993
12. 123I]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates. Synapse 13: 295-309, 1993
13. Ogasawara K, Hashimoto J, Ogawa K, Kubo A, Motomura N, Hasegawa H, Ichihara T: Simultaneous acquisition of iodine-123 emission and technetium-99 m transmission data for quantitative brain single-photon emission tomographic imaging. Eur J Nucl Med 25: 1537-1544, 1998
14. Quinn N: Multiple system atrophy. pp 262-281 (ed by Marsden CD, Fahn S: In Movement Disorders, vol 3, Butterworths-Heinemann, London, 1994)
15. Shinotou H, Hirayama K, Tateno Y: Dopamine D 1 and D 2 receptors in Parkinson's disease and striatonigral degeneration determined by PET. Adv Neurol 60: 488-493, 1993
16. Tolosa E, Valldeoriola F, Marti MJ: Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neural Transm 42: 15-31, 1994
17. Wagner HN, Burns DH, Dannals RF, Wong DF, Langstrom B, Duelfer T, Frost JJ, Ravert HT, Links JM, Rosenbloom SB, Lukas SE, Kramer AV, Kuhar MJ: Imaging dopamine receptors in the human brain by positron tomography. Science 221: 1264-1266, 1983
18. Rutgers AWF, Lakke JPWF, Paans AMJ, Vaalburg W, Korf J: Tracing of dopamine receptors in hemiparkinsonism with positron emission tomography (PET). J Neurol Sci 80: 237-248, 1987
19. Wolters EC, Huang CC, Clark C, Peppard RF, Okada J, Chu NS, Adam MJ, Ruth TJ, Li D, Calne DB: Positron emission tomography in manganese intoxication. Ann Neurol 26: 647-651, 1989
20. Yamanouchi H, Nagura H: Neurological sign and frontal white matter lesions in vascular parkinsonism: A clinicopathologic study. Stroke 28: 965-969, 1997